Funds holding Aquestive Therapeutics Inc
ISIN US03843E1047 · United States
- Fund holders
- 122
- Of which ETFs
- 22 100 other funds
- Value held
- ≈ 72.1M $ 71.8M $ · 222.7K €
- Share of capital
- 13.9 % of 125.5M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,122 | 8.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,011 | 8.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 1,958 | 8.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 1,587 | 6.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,152 | 4.7K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 622 | 2.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 567 | 2.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 540 | 2.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Quality ETF American Century ETF Trust | 482 | 1.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 439 | 1.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 349 | 1.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 341 | 1.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 258 | 1.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 228 | 946.2 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 202 | 838.3 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 186 | 762.6 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 121 | 502.2 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 107 | 428 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 77 | 319.6 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 32 | 128 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 23 | 95.5 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 222.7K € | 0.27 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 1.40 % | as of Mar 31, 2026 ↗ |
| Wasatch Ultra Growth Fund WASATCH FUNDS TRUST | 0.88 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 0.81 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 0.78 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.56 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.55 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value Fund Federated Hermes Equity Funds | 0.40 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 0.30 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Small Cap Core ETF Federated Hermes ETF Trust | 0.27 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.27 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 121 | +4 | 17,413,333 | +5.4 % |
| 2026Q1 | 117 | +15 | 16,515,696 | +18.2 % |
| 2025Q4 | 102 | +6 | 13,974,241 | +30.7 % |
| 2025Q3 | 96 | 0 | 10,693,458 | +6.2 % |
| 2025Q2 | 96 | +3 | 10,064,561 | -10.6 % |
| 2025Q1 | 93 | +5 | 11,261,872 | +3.5 % |
| 2024Q4 | 88 | +50 | 10,886,069 | +32.3 % |
| 2024Q3 | 38 | +20 | 8,229,055 | +57.3 % |
| 2024Q2 | 18 | +2 | 5,231,790 | +87.5 % |
| 2024Q1 | 16 | +1 | 2,790,160 | +20.0 % |
| 2023Q4 | 15 | 2,325,967 |
Institutional managers
178 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | 40.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7,509,071 | 31.2M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 7,426,471 | 30.8M $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,443,698 | 18.4M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 2,940,339 | 12.2M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 2,900,570 | 12M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,546,191 | 10.6M $ | as of Mar 31, 2026 |
| SAMSARA BIOCAPITAL, LLC | 2,500,000 | 10.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,408,191 | 10M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,405,050 | 10M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 1,922,887 | 8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,591,792 | 6.6M $ | as of Mar 31, 2026 |
| Blue Owl Capital Holdings LP | 1,347,932 | 5.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,139,404 | 4.7M $ | as of Mar 31, 2026 |
| Janney Montgomery Scott LLC | 1,089,110 | 4.5K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 1,082,680 | 4.5M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 1,034,644 | 4.3M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 1,030,050 | 4.3M $ | as of Mar 31, 2026 |
| WASATCH ADVISORS LP | 878,316 | 3.6M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 809,007 | 3.4M $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 799,163 | 3.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 732,504 | 3M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 710,988 | 3M $ | as of Mar 31, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 691,750 | 2.9M $ | as of Mar 31, 2026 |
| VANGUARD FIDUCIARY TRUST CO | 637,512 | 2.6M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Aquestive Therapeutics Inc". https://titelia.com/en/stocks/aquestive-therapeutics-inc-US03843E1047